相关临床试验
7
1 进行中
药物批准
0
批准总数
监管机构
0
监管机构数
成立时间
N/A
进行中（未招募）
1
14.3%
已完成
6
85.7%
暂无批准数据
- Accenture has made a strategic investment through Accenture Ventures in Ryght AI, a platform provider that modernizes clinical research design and execution for life sciences companies. - Ryght AI's AI Site Twin platform creates dynamic digital replicas of clinical research sites worldwide, incorporating historical performance data, patient demographics, and real-time operational insights to streamline site selection and patient enrollment. - The collaboration aims to accelerate three critical stages of drug development: trial feasibility assessment, site selection, and patient recruitment, helping bring new treatments to patients faster. - The investment addresses growing complexity in clinical trials that has led to major delays, with manual site selection processes adding weeks or months to study timelines and increasing development costs.
- Moderna has formed a strategic partnership with IBM to leverage quantum computing and generative artificial intelligence for advancing mRNA medicine discovery and development. - The collaboration aims to deepen understanding of mRNA molecular behavior, refine molecular structures, and improve lipid nanoparticle delivery systems used in mRNA therapeutics. - Moderna joins a growing group of pharmaceutical companies including Biogen and Bayer that are embracing quantum computing technologies to accelerate drug discovery processes. - The partnership positions Moderna to harness quantum computing's potential to investigate larger molecules and solve previously intractable problems in mRNA research.
- Medical technologist Nick Webb emphasizes that future healthcare success will depend on creating a 'beautiful human experience' alongside clinical excellence, focusing on workforce and patient happiness. - Healthcare organizations must embrace multimodal AI integration within the next 36 months, utilizing the technology to automate routine tasks while allowing staff to work at their highest potential. - Simple solutions to improve workforce satisfaction, combined with consumer-centric approaches and AI automation, are key to achieving scalable revenue growth and enhanced care delivery.
- The pharmaceutical industry is undergoing a major digital transformation accelerated by COVID-19, with companies expected to invest $30 billion in digital initiatives focusing on AI and Machine Learning technologies. - Digital solutions are addressing key industry challenges including data gaps in clinical trials, ineffective communication between teams, and growing patient demands for personalized care and faster access to treatments. - Advanced technologies like AI and ML are revolutionizing drug discovery, supply chain management, and patient care through improved data analysis, automated processes, and personalized treatment approaches.
